talis.bio (TLIS) Company Sales

Corporate emblem and logo of Talis Biomedical Corporation (TLIS)

Talis Biomedical (TLIS) is currently pivoting its business model, preserving assets to monetize its proprietary software. Demand for such rapid tests remains stable even during crises, particularly in winter. The company's commercial sales metric reflects the current cash inflow rate, with the value fixed at 0.00. Efficiency is maintained through outsourced electronics manufacturing and international reagent logistics.

TLIS Talis Biomedical Corporation: Revenue and Sales Volume in the range 07/04/2022 - 09/07/2024

Comprehensive metric breakdowns and analytics for Talis Biomedical Corp. (TLIS)

- share price and expert price forecast:
Price Performance Chart Talis Biomedical Corp|TLIS - Price Target Chart
- market capitalization details:
Market Valuation Talis Biomedical Corporation|TLIS - Enterprise Value
- balance sheet equity data:
Net Asset Value per Share Talis Biomedical|TLIS - Book Capitalization|Capitalization to Book Value Ratio talis.bio|TLIS - Company Total Assets
- debt and solvency information:
Total Debt to Capital Coefficient Talis Biomedical|TLIS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Talis Biomedical Corp|TLIS - Company Aggregate Debts|Debts to Book Capitalization Talis Biomedical Corporation|TLIS - Company Long-Term Debt|Company Short-Term Debt Talis Biomedical|Intermediate Coverage Ratio talis.bio
- business earnings and investment ratios data:
TLIS - Net Profit|Expected Net Profit Talis Biomedical|TLIS - Price to Earnings Ratio|Forward Price to Earnings Multiple Talis Biomedical Corp|TLIS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Talis Biomedical Corporation|TLIS - Operating profit EBITDA|Net earnings per share for the last four quarters Talis Biomedical|TLIS - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months talis.bio|TLIS - Earnings per share growth in current year|Expected earnings per share growth for next year Talis Biomedical
- company sales and revenue statistics:
TLIS - Revenue and Sales Volume|Company Expected Sales Volume Talis Biomedical Corp|TLIS - Price-to-Revenue Ratio|Market Cap to Projected Revenue Talis Biomedical Corporation
Summary company analysis:TLIS, talis.bio
Manufactured product of Talis Biomedical

For Talis Biomedical (TLIS), whose defensive market barriers have been neutralized by delisting and the cessation of operations, operating cash flow is virtually exhausted. This indicator aggregates daily revenue from the sale of diagnostic systems, allowing investors to assess financial stability and the consistency of inflows, while the company's sales statistics clearly demonstrate a critical decline in the issuer's commercial activity.

Analysis of competing companies

ABT: Company Sales Revenue|Company Revenue Thermo Fisher Scientific (TMO)|Company Sales gehealthcare.com GEHC|Revenue and Sales Volume MTD (Mettler Toledo)|Waters Corp (WAT) - Company Total Revenue|Techne Corporation - Revenue and Sales Volume|BRKR (Bruker BioSpin) - Company Sales Volume|AZTA: Revenue and Sales Volume|VREX - Company Gross Revenue|SMLR (Semler Scientific) - Revenue and Sales Volume|Company Sales Butterfly Network Inc (BFLY)|Revenue and Sales Volume MLAB|Revenue and Sales Volume Quantum-Si Corporation (QSI)|Company Revenue Nano-X Imaging Ltd. NNOX|quanterix.com - Company Revenue|MASS: Company Sales|Company Sales Revenue CV (CapsoVision Inc)|MXCT: Revenue and Sales Volume|Company Total Revenue Rapid Micro Biosystems, Inc. (RPID)|Company Revenue Seer, Inc.|HYPR - Company Total Sales Volume|Company Sales FONR (FONAR)|Revenue and Sales Volume daxor.com (DXR)|Revenue and Sales Volume MDAI (Spectral AI, Inc.)|Company Gross Revenue Organovo Holdings, Inc. (VIVS)|ACON - Company Revenue|Company Annual Revenue AKYA|ThermoGenesis Holdings (THMO) - Company Revenue|Company Sales T2 Biosystems Inc.